Longitudinal Mult-omics Study of Palbociclib Resistance in Hormone Receptor (HR) Positive/Human Epidermal Growth Factor Receptor (HER) 2 Negative Metastatic Breast Cancer (MBC)

ABSTRACT: A comprehensive genomic and transcriptomic analysis of pre-treatment and post-treatment tumors from Asian metastatic breast cancer patients treated with palbociclib plus endocrine therapy identified novel markers associated with poor prognosis.

ORGANISM(S): Homo sapiens

PROVIDER: GSE186901 | GEO | 2023/05/09

REPOSITORIES: GEO